BrabantZorg

BrabantZorg stands for care with attention. Attention for people, for our work and for each other. We help people to live pleasantly, in a familiar and safe environment and support them to take control themselves. A life in which something can be chosen, in which not the rules or restrictions are central, but the relationship between people who want to mean something for each other. In the Netherlands we are among the front-runners in care for the elderly because we consider human warmth and involvement self-evident, as does quality and professionalism in our work. That is our mission. Every day again. That's us. That is BrabantZorg.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

18th International Conference on Metabolomics and Systems Biology

Conference

5th Commercializing Industrial Biotechnology

Conference

Neurodegeneration and Proteostasis

Webinar

Harnessing and Mimicking the Reactivity of Biological Metals for a Healthy and Sustainable Future

Conference

International Conference on Advances in Biological Science and Technology

Conference

BiotechForum2022

Conference

Related News

GSK COLLABORATES WITH VIR BIOTECHNOLOGY TO FIND CORONAVIRUS SOLUTIONS

HospiMedica International | April 07, 2020

GlaxoSmithKline plc (London, UK) and Vir Biotechnology, Inc. (San Francisco, CA, USA) have entered into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. The collaboration will use Vir’s proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used as therapeutic or preventative options to help address the current COVID-19 pandemic and future outbr...

TAVOTEK ANNOUNCES A RESEARCH AGREEMENT WITH GENMAB FOR THE DEVELOPMENT OF BISPECIFIC ANTIBODIES

Tavotek | May 25, 2020

Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered into a research agreement with Genmab A/S of Denmark to create and develop bispecific antibodies using Genmab's DuoBody® technology platform against disease relevant target antigens. Tavotek employs TavoSelect™, with proprietary VHO phage and Fab phage libraries, to efficiently identify lead molecules for generation of bispecific antibodies a...

PHARMABCINE EXPANDS PARTNERSHIP WITH SAMSUNG BIOLOGICS FOR PMC-403

PharmAbcine Inc. | September 21, 2020

PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Samsung Biologics (KRX: 207940.KS) for the development and manufacturing of PMC-403 pipeline, the next generation therapeutic antibody candidate to treat neovascular disorders. Samsung will provide the full scope of its CDO services from cell line development, process development, cGMP clinical manufacturing to IND filing support. PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibo...

MEDTECH

OUTCOMES4ME PARTNERS WITH INVITAE TO OFFER GENETIC TESTING TO BREAST CANCER PATIENTS

Outcomes4Me | October 12, 2021

Outcomes4Me Inc., developer of a leading free mobile app and platform to navigate cancer treatment and care, today announced that it has partnered with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to expand education and access to genetic testing to breast cancer patients and survivors. The collaboration leverages the strengths of Invitae, which supplies clinical grade genetic testing, and Outcomes4Me’s 360-degree, validated and evidence-based cancer support and tr...